SCOTTSDALE, Ariz.,October 26, 2015 /MJbizwire/ –Northsight Capital, Inc. (OTCBB: NCAP) announced today the appointment of John B. Hollister as CEO. Mr. Hollister brings more than 25 years of commercial management and fundraising experience in related pharmaceutical, biotech and medical device fields including SmithKline Beecham and Amgen. Most recently, as the CEO and Director of NEMUS Bioscience, a biopharmaceutical company developing cannabis-derived pharmaceutical products, Hollister successfully raised over $7M in working capital, including the most recent round of $5M. (Hollister is one of the few executives in the cannabis space who have successfully completed a major funding) As a Director and Global […]
Northsight Capital Appoints Pharmaceutical and Biotech Sales Industry Veteran John B. Hollister as Chief Executive Officer
Oct 26, 2015
